161 related articles for article (PubMed ID: 1555751)
1. Decreased protein concentration and improved metastability of bile induced by ursodeoxycholate.
Chijiwa K; Hirota I; Noshiro H
Gastroenterol Jpn; 1992 Feb; 27(1):88-94. PubMed ID: 1555751
[TBL] [Abstract][Full Text] [Related]
2. Total protein content of human gallbladder bile: relation to cholesterol gallstone disease and effects of treatment with bile acids and aspirin.
Sahlin S
Eur J Surg; 1996 Jun; 162(6):463-9. PubMed ID: 8817223
[TBL] [Abstract][Full Text] [Related]
3. Effects of long-term ursodeoxycholate administration on expression levels of secretory low-molecular-weight phospholipases A2 and mucin genes in gallbladders and biliary composition in patients with multiple cholesterol stones.
Kano M; Shoda J; Irimura T; Ueda T; Iwasaki R; Urasaki T; Kawauchi Y; Asano T; Matsuzaki Y; Tanaka N
Hepatology; 1998 Aug; 28(2):302-13. PubMed ID: 9695991
[TBL] [Abstract][Full Text] [Related]
4. Effect of chenodeoxycholate and ursodeoxycholate on nucleation time in human gallbladder bile.
Hirota I; Chijiiwa K; Noshiro H; Nakayama F
Gastroenterology; 1992 May; 102(5):1668-74. PubMed ID: 1568577
[TBL] [Abstract][Full Text] [Related]
5. Low-dose ursodeoxycholic acid prolongs cholesterol nucleation time in gallbladder bile of patients with cholesterol gallstones.
Jüngst D; Brenner G; Pratschke E; Paumgartner G
J Hepatol; 1989 Jan; 8(1):1-6. PubMed ID: 2921499
[TBL] [Abstract][Full Text] [Related]
6. Ursodeoxycholic acid reduces protein levels and nucleation-promoting activity in human gallbladder bile.
Van Erpecum KJ; Portincasa P; Eckhardt E; Go PM; VanBerge-Henegouwen GP; Groen AK
Gastroenterology; 1996 Apr; 110(4):1225-37. PubMed ID: 8613013
[TBL] [Abstract][Full Text] [Related]
7. Stabilization of biliary lipid particles by ursodeoxycholic acid. Prolonged nucleation time in human gallbladder bile.
Mizuno S; Tazuma S; Kajiyama G
Dig Dis Sci; 1993 Apr; 38(4):684-93. PubMed ID: 8462368
[TBL] [Abstract][Full Text] [Related]
8. Biliary lipid composition in patients with cholesterol and pigment gallstones and gallstone-free subjects: deoxycholic acid does not contribute to formation of cholesterol gallstones.
Gustafsson U; Sahlin S; Einarsson C
Eur J Clin Invest; 2000 Dec; 30(12):1099-106. PubMed ID: 11122325
[TBL] [Abstract][Full Text] [Related]
9. High vesicular cholesterol and protein in bile are associated with formation of cholesterol but not pigment gallstones.
Chijiiwa K; Hirota I; Noshiro H
Dig Dis Sci; 1993 Jan; 38(1):161-6. PubMed ID: 8420750
[TBL] [Abstract][Full Text] [Related]
10. Comparative evaluation of chenodeoxycholic and ursodeoxycholic acids in obese patients. Effects on biliary lipid metabolism during weight maintenance and weight reduction.
Mazzella G; Bazzoli F; Festi D; Ronchi M; Aldini R; Roda A; Grigolo B; Simoni P; Villanova N; Roda E
Gastroenterology; 1991 Aug; 101(2):490-6. PubMed ID: 2065925
[TBL] [Abstract][Full Text] [Related]
11. The effect of vitamin C in high doses on plasma and biliary lipid composition in patients with cholesterol gallstones: prolongation of the nucleation time.
Gustafsson U; Wang FH; Axelson M; Kallner A; Sahlin S; Einarsson K
Eur J Clin Invest; 1997 May; 27(5):387-91. PubMed ID: 9179545
[TBL] [Abstract][Full Text] [Related]
12. Combined bile acid therapy is more effective on biliary lipids and dissolution rates than monotherapy after gallstone lithotripsy.
Tudyka J; Kratzer W; Janowitz P; Mason R; Wechsler JG
Am J Gastroenterol; 1995 Nov; 90(11):1942-8. PubMed ID: 7484996
[TBL] [Abstract][Full Text] [Related]
13. Effects of combined treatment with pravastatin and ursodeoxycholic acid on hepatic cholesterol metabolism.
Hillebrant CG; Nyberg B; Gustafsson U; Sahlin S; Björkhem I; Rudling M; Einarsson C
Eur J Clin Invest; 2002 Jul; 32(7):528-34. PubMed ID: 12153554
[TBL] [Abstract][Full Text] [Related]
14. Activity of cholesterol in human gallbladder bile in relation to nucleation of cholesterol monohydrate crystals.
Noshiro H; Chijiiwa K; Hirota I
Clin Chim Acta; 1992 Feb; 205(3):167-79. PubMed ID: 1576744
[TBL] [Abstract][Full Text] [Related]
15. Behavior of various cholesterol crystals in bile from patients with gallstones.
Portincasa P; van Erpecum KJ; Jansen A; Renooij W; Gadellaa M; vanBerge-Henegouwen GP
Hepatology; 1996 Apr; 23(4):738-48. PubMed ID: 8666327
[TBL] [Abstract][Full Text] [Related]
16. Bile lithogenicity and gallbladder emptying in patients with microlithiasis: effect of bile acid therapy.
Sharma BC; Agarwal DK; Dhiman RK; Baijal SS; Choudhuri G; Saraswat VA
Gastroenterology; 1998 Jul; 115(1):124-8. PubMed ID: 9649467
[TBL] [Abstract][Full Text] [Related]
17. Routine determination of biliary lipid composition with the entero-test.
Muraca M; Pazzi P; Vilei MT; Miconi L; Granato A; Cianci V; Sighinolfi D; Alvisi A; Gerunda G; Maffei Faccioli A
Ann Chir; 1994; 48(2):197-200. PubMed ID: 8192414
[TBL] [Abstract][Full Text] [Related]
18. A combination therapy with simvastatin and ursodeoxycholic acid is more effective for cholesterol gallstone dissolution than is ursodeoxycholic acid monotherapy.
Tazuma S; Kajiyama G; Mizuno T; Yamashita G; Miura H; Kajihara T; Hattori Y; Miyake H; Nishioka T; Hyogo H; Sunami Y; Yasumiba S; Ochi H; Matsumoto T; Abe A; Adachi K; Omata F; Ueno F; Sugata F; Ohguri S; Shibata H; Kokubu S
J Clin Gastroenterol; 1998 Jun; 26(4):287-91. PubMed ID: 9649013
[TBL] [Abstract][Full Text] [Related]
19. The effect of ursodeoxycholic acid on nucleation time in patients with solitary or multiple gallbladder stones.
Tudyka J; Wechsler JG; Mason R; Maier C
Am J Gastroenterol; 1994 Aug; 89(8):1206-10. PubMed ID: 8053436
[TBL] [Abstract][Full Text] [Related]
20. Effects of a concanavalin A-binding biliary glycoprotein on nucleation time of gallbladder bile.
Nakano A; Masuzawa S; Ogura K; Fukazawa S; Nakamoto K; Sekido H; Fukushima T; Tsuchiya S
Gastroenterol Jpn; 1990 Feb; 25(1):88-92. PubMed ID: 2307338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
